Home » SAVIENT ANNOUNCES CHANGES TO THE BOARD
SAVIENT ANNOUNCES CHANGES TO THE BOARD
East Brunswick-based Savient Pharmaceuticals has announced that Lee S. Simon, Alan L. Heller and Joseph Klein III will seek the positions of independent directors of the firm during a May 23 election. The trio will run for slots vacated by current chairman Jeremy Hayward-Surry, Herbert Weissbach and Carl Kaplan, who have retired from the board or announced plans to step down. NJBIZ (http://www.njbiz.com/article.asp?aID=13571022.986536.869791.5593551.6450358.413&aID2=66898)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May